List jobs that are going to be downsized here

The last post missed the point. The retail reps are the ones generating and driving business. Whether it's one prescription or a thousand, they earn their keep. A CAM? They talk a mean game..."after reviewing the latest Q3 financials I can see that turnover was lower. We should develop a plan of action which would allow for increased payer access. Perhaps YOU could schedule value added program within one of our accounts..blah blah blah". Sound familiar? Then you get an FBM cracking the whip and asking completely out of touch questions like, "I understand that provider access is much worse than it was ten years ago, but can you still make 8 calls per day on targets the the company provided(not knowing of course that said providers have a no-rep policy)? Then the FBM gets out of bed and gets ready for the gym. Think I am kidding? How about the "Business Improvement" position? What a complete joke! The company got it right for once. They kept the people who make a difference to the bottom line. Wish everyone the best but with a word to the wise. Always remember that any job is a good job but if you have a choice, take the job that actually matters to the employer. CAMs & HAMs, the chickens have come home to roost. You had five years of sucking off the GSK teat snd doing little else. Did you really think you all were going to do nothing but collect a paycheck with great perks for doing nothing? The music has ended. Time to pay the piper.

 

The objective evidence was always there- she left lly in ruins. Hiring her was an act if fiduciary malfeasance!

 

Gimme a break! You're not earning your keep. Advair is keeping you alive. Breo and Anoro have been miserable failures and they are not revenue positive in any territory. When Advair goes bye bye you will be in the same position as the ship REALLY starts sinking when Advair goes generic.

Better stop throwing those stones at glass houses. Your time is coming.

 

So let me get this straight. If the retail based reps would have sold more then more of the support staff could have pretend jobs that make them sound important. Why not just sell more and not have all of these positions? You know make more profit.

I will agree with your last point about being on the chopping block. I will also say that retail reps are not being retained because of their performance but simply because you can't grow sales without sales reps.
Please keep this in mind though. The retail reps like you followed the GSK plan. You know the one where we ask for lots of activity, reach and frequency, calls per day, peer to peer, sample attainment...but nothing about results. The company doesn't even call it sales or prescriptions anymore. It's called "Lag" indicators. This selling model endorsed by this leadership team has put us in this box. Not HAMs, CAMs, RCE's, FBMs, or retail reps...the only difference is that the company can move on without everyone except the retail reps.

If at the end of the year sales suck the company will be left with another decision to make. Cut retail reps and hope sales magically improve with fewer people or replace senior leadership and the selling model. Sales are so low that there is no way to save your way to prosperity on this one. Firing reps that speak to our largest customers won't solve anything. That doesn't mean it won't happen but it just won't solve their problem.

Payer markets arrogance around Advair contracting along with the current selling model caused this blood bath. Not you, me, or any other reps.

 

excellent and all true.....

 

Post #44-that is the honest truth. Our organization better wake up because we are still sliding downward on that slippery slope!

 

Retail sales reps earn their keep by definition and by fact. Their role is to generate sales. Be it pull through of managed care or be it direct influence with face to face interactions with the customer. Reps are a necessary evil to almost every company in every industry. They generate revenue. $1 or $1,000,000 they bring in money. Like it or not, it is the truth. Company finally got it right for once.

 

http://www.bloomberg.com/news/2014-12-03/glaxo-to-eliminate-several-hundred-u-s-jobs-to-reduce-costs.html

Glaxo to Cut 900 Jobs in North Carolina to Reduce Expenses

 

#48. "Jane you ignorant slut"

 

#44 it was not arrogance, it was advanced analytics!

 

Where do you work in the company that generates so much revenue? Bad company leadership and decisions like the Advair Medco situation and the nuts and bolts of PF the are why retail reps aren't generating more revenue. Managers can't even compare sales results of reps or risk getting canned. Field reps in this company now should be called customer service reps because no one cares about sales. Reps gets bonused on R&F, test scores, and maybe the COTS (a ridiculously long list of check boxes managers do in field).

 

Generic Symbicort mid-late 2015. No hospitals will take Breo or Advair versus $10-$20 Symbicort. No need for MedCenter. 6 month exclusivity will help retail until year-end, or early 2016, but all the coupons in the world won't help with $4 generic Symbicort. Thus, the sense of panic, er, urgency around getting patients started quickly. Why do you think AZ and GSK are focusing on locking up patients with free medication and low copays? Why do you think JB wouldn't negotiate with ESI? We needed to pull as many dollars as possible from Advair, to survive a little longer. We're coming to the end of the road folks. GSK respiratory will be a small division of 500 reps with a more expensive once/day Ellipta device this time next year.

 

Symbicort patent is solid until at least 2018. Mylan is targeting AB Advair in 2017

 

Just figuring that out. It has be sliding since 2007-2008, shortly after the merger.

 

Since you are the OP, we can all see the reason for the post--now you had to cut to the chase huh??!! LOL---when I was there is was 12K reps--you will be lucky to have 500 PC reps 3 yrs from now, and zero within 8 yrs--yeppers--zippo- HR here with great sources--not A GOOD source--SOURCES

 

Twas not a merger....SKB took over GW in 2000, not 2007.

 

GSK doesn't need the Novartis vaccine people anymore than Novartis needs GSK oncology people.